RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Brentuximab Vedotin – First Treatment Option for Relapsed Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (Subset of Non-Hodgkin Lymphoma)
May 2011 - 5 pages - $500
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Lymphoma Therapy Area Pipeline Report
Nov 2010 - 233 pages - $1,495
Hodgkin Lymphoma Therapy Area Pipeline Report
Nov 2010 - 143 pages - $1,495
Non-Hodgkin Lymphoma Therapy Area Pipeline Report
Nov 2010 - 622 pages - $1,495
Cutaneous T-cell Lymphoma Therapy Area Pipeline Report
Nov 2010 - 101 pages - $1,495
Follicular Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 213 pages - $500
Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 672 pages - $500
Mantle Cell Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 268 pages - $500
Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential
Dec 2010 - 126 pages - $3,500
More Related Market Research Reports >>>

Your selection

Therapeutic target
Oncology del
Lymphoma del
Neoplastic disease del
Year
2002 del

Browse By

Industry sector
Academic/Research
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Non-profit org./Government
Pharmaceutical
Research tools
Service

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us